April 23 (Reuters) - U.S. drugmaker AbbVie Inc reported a 4 percent rise in quarterly profit, driven by strong sales of its arthritis drug, Humira.

The company’s profit rose to $1.02 billion, or 63 cents per share, in the first quarter ended March 31, from $980 million, or 61 cents per share, a year earlier.

On an adjusted basis, the company earned 94 cents per share.

Revenue rose 10.5 percent to $5.04 billion. (Reporting by Ankur Banerjee in Bengaluru; Editing by Maju Samuel)